Merck KGaA (MKKGY) to Announce Earnings on Thursday

Merck KGaA (OTCMKTS:MKKGY) is expected to post its results before the market opens on Thursday, August 6th. Analysts expect the company to post earnings of $0.47 per share and revenue of $6.0806 billion for the quarter.

Merck KGaA (OTCMKTS:MKKGY) last announced its quarterly earnings results on Wednesday, May 13th. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.14. Merck KGaA had a return on equity of 8.79% and a net margin of 12.07%.The company had revenue of $6.03 billion during the quarter, compared to analysts’ expectations of $5.93 billion. On average, analysts expect Merck KGaA to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Merck KGaA Trading Up 2.8%

Shares of OTCMKTS:MKKGY opened at $33.83 on Wednesday. Merck KGaA has a 12-month low of $23.73 and a 12-month high of $34.19. The company has a market capitalization of $21.86 billion, a PE ratio of 15.04, a PEG ratio of 2.89 and a beta of 0.98. The business has a 50 day moving average of $31.86 and a two-hundred day moving average of $29.14. The company has a current ratio of 1.51, a quick ratio of 1.00 and a debt-to-equity ratio of 0.36.

Analysts Set New Price Targets

Several research firms have recently weighed in on MKKGY. Jefferies Financial Group began coverage on shares of Merck KGaA in a report on Tuesday, May 26th. They set a “hold” rating for the company. Zacks Research raised shares of Merck KGaA from a “hold” rating to a “strong-buy” rating in a report on Wednesday, July 22nd. Finally, HSBC upgraded shares of Merck KGaA to a “hold” rating in a research report on Monday, July 6th. One research analyst has rated the stock with a Strong Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold”.

Merck KGaA Company Profile

Merck KGaA, Darmstadt, Germany, commonly referred to as Merck Group, is a multinational science and technology company with origins dating back to 1668. The company develops and manufactures products and technologies across healthcare, life science and electronics applications. It is distinct from the U.S. pharmaceutical company Merck & Co; Merck KGaA is a European group headquartered in Darmstadt and is publicly listed in Germany with an OTC American depositary receipt available under the symbol MKKGY.

Merck’s Healthcare business develops prescription medicines and related services focused on areas such as oncology, immunology, neurology (including therapies for multiple sclerosis) and fertility.